Obalon Therapeutics Inc. | Mutual Funds
Mutual Funds that own Obalon Therapeutics Inc.
Carnegie Global Health Care Fund
315,504
1.77%
-9,758
0.5%
08/31/2018
Vanguard Total Stock Market Index Fund
254,939
1.43%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
173,018
0.97%
0
0%
07/31/2018
Formula Growth Fund
74,998
0.42%
74,998
0.09%
12/31/2016
Alger Health Sciences Fund
46,795
0.26%
0
0.07%
01/31/2018
Bridgeway Ultra Small Company Market Fund
45,000
0.25%
20,000
0.03%
12/31/2017
Altair Smaller Companies Fund
34,321
0.19%
0
0.03%
02/28/2018
iShares Micro Cap ETF
24,100
0.14%
0
0.01%
09/06/2018
Fidelity Spartan Small Cap Index Fund
17,904
0.1%
-95
0%
04/30/2018
CREF Stock Account
17,478
0.1%
0
0%
03/31/2018
| Address |
5421 Avenida Encinas
Carlsbad California 92008
United States
|
|
Employees
|
- |
| Website |
http://www.obalon.com |
| Updated |
07/08/2019 |
| Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded in January 2008 and is headquartered in San Diego, CA. |
